0001567619-18-001854.txt : 20180828 0001567619-18-001854.hdr.sgml : 20180828 20180828180454 ACCESSION NUMBER: 0001567619-18-001854 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180824 FILED AS OF DATE: 20180828 DATE AS OF CHANGE: 20180828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Adrian CENTRAL INDEX KEY: 0001438326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 181042593 MAIL ADDRESS: STREET 1: 1010 N. CENTRAL AVENUE STREET 2: SUITE 201 CITY: GLENDALE STATE: CA ZIP: 91202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-839-5200 MAIL ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 4 1 doc1.xml FORM 4 X0306 4 2018-08-24 0 0001083446 Apollo Medical Holdings, Inc. AMEH 0001438326 Vazquez Adrian 700 N. BRAND BLVD. SUITE 1400 GLENDALE CA 91203 0 1 0 0 Co-Chief Medical Officer Common Stock 2018-08-24 4 M 0 30000 1.5 A 942338 D Common Stock 2018-08-24 4 M 0 10000 10 A 952338 D Common Stock 2018-08-24 4 M 0 18574 6.37 A 970912 D Stock Option (right to buy) 1.5 2018-08-24 4 M 0 30000 0 A 2010-12-09 2020-12-08 Common Stock 30000 33400 D Stock Option (right to buy) 10 2018-08-24 4 M 0 10000 0 A 2014-07-10 2024-07-10 Common Stock 10000 23400 D Stock Option (right to buy) 6.37 2018-08-24 4 M 0 18574 0 A 2016-09-14 2021-02-14 Common Stock 18574 4826 D One third (1/3) of the shares subject to the option vested on December 9, 2010, December 9, 2011 and December 9, 2012, respectively. One thirty-sixth (1/36) of the shares subject to the option vested on July 10, 2014 and on each monthly anniversary of July 10, 2014, respectively. The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's stockholders approved the plan on September 14, 2016. The option vested as to 15,584 shares on February 15, 2016 and the balance of the shares subject to the option vested at a rate of approximately 651 shares per month commencing on March 15, 2016. The acquisition of the Issuer's common stock reported on this Form 4 resulted from the exercise of options granted by the Issuer's Compensation Committee, a committee solely composed of two or more non-employee directors, and is therefore exempt from section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to rule 16b-3(d)(1) thereunder. Adrian Vazquez 2018-08-28